Bio/Pharmaceutical Outsourcing Report, July 2026
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.
Scope
This report gives an important monthly update on the pharmaceutical outsourcing industry, based on analysis from GlobalData's experts and our databases covering deals, companies, drugs, financials, news, clinical trials, and more. This report is required reading for –
– CMO executives and strategic decision-makers: to improve understanding of the CMO industry and provide a critical input for strategic planning efforts.
– Sourcing and procurement executives in bio/pharmaceutical companies: to improve understanding of crucial components of the supply base that will provide insights for supplier selection and management.
– Investors, advisors, and consultants: they can gain a deeper understanding of the CMO market and important insights for identifying potential investment targets.
Reasons to Buy
Understand current trends and equip yourself with forward-thinking strategies to navigate challenges and capitalise on emerging trends driving the pharmaceutical manufacturing industry. Use our radar to identify developments and innovations with high impact.
Discover the latest opportunities and threats in the contract manufacturing industry, based on clinical trials and regulatory decisions.
Learn about the past quarter’s M&A and financing deals in the manufacturing space.
Identify the latest contract service agreements.
Develop your competitor or market intelligence by reading about inspection outcomes and facility investments.
Stay ahead of disruption with updates on supply chain obstacles and new regulations.
AIM ImmunoTech Inc
Amneal Pharmaceuticals Inc
Ankyra Therapeutics Inc
Argonaut Manufacturing Services LLC
Avanti Polar Lipids Inc
BlueRock Therapeutics LP
Bora Biologics Co Ltd
BriaCell Therapeutics Corp
Cabaletta Bio Inc
Catalent Inc
Cellares Corp
Charles River Laboratories International Inc
Cynata Therapeutics Ltd
Dai Nippon Printing Co Ltd
Eli Lilly Group Limited
Ensera Inc
Evonik Industries AG
FUJIFILM Cellular Dynamics Inc
GC Green Cross Corp
GSK plc
Insilico Medicine
Intertek Group Plc
Intravacc BV
Jubilant HollisterStier LLC
KBI Biopharma Inc
Korea Vaccine Co Ltd
Kyowa Kirin Co Ltd
Lonza Group Ltd
Lotte Biologics Co Ltd
Lupin Ltd
Nitto Avecia Pharma Services Inc
NovoArc
Olpha
Patheon NV
PCI Pharma Services
Pharmaceutics International Inc
Prestige Biopharma Ltd
ProBioGen AG
Pyramid Laboratories Inc
Recipharm AB
Rottendorf Pharma GmbH
Samsung Biologics Co Ltd
Sandoz AG
Siegfried Holding AG
Tricida Inc
Vaccinex Inc
WuXi AppTec Co Ltd
Table of Contents
Table
Figures
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Contract Manufacturers reports